Showing 7941-7950 of 9428 results for "".
- Is a Topical Gel Made From Oral Blood Pressure Drugs a Panacea for Wound Healing, Wrinkles and More?https://practicaldermatology.com/news/is-a-topical-gel-made-from-oral-blood-pressure-drugs-a-panacea-for-wound-healing-wrinkles-and-more/2457989/Topical gel made from angiotensin II receptor blockers may speed the healing of chronic skin wounds in mice and pigs, Johns Hopkins researchers report. The findings, published in the Journal of Investigative Dermatology, marks efforts to seek approval from the U.S. Food and Drug
- Exuviance Introduces New Detox Mud Treatmenthttps://practicaldermatology.com/news/exuviance-introduces-new-detox-mud-treatment/2458001/Exuviance is rolling out their new Detox Mud Treatment. The Exuviance Detox Mud Treatment is formulated with three key ingredients: 23 percent Active Charcoal, Clay, and NeoGlucosamine® for a refined, smoother complexion. The patented no
- Understanding How and When UV Rays Cause Melanomashttps://practicaldermatology.com/news/understanding-how-and-when-uv-rays-cause-melanomas/2458002/When melanocyte stem cells accumulate a sufficient number of genetic mutations, they can become the cells where melanomas originate, Cornell University researchers report. Under normal conditions, ultraviolet (UV) radiation from the sun activates melanocytes to release melanin, but if mel
- PruGen Pharmaceuticals Takes Action to Aid Hurricane Relief Effortshttps://practicaldermatology.com/news/prugen-pharmaceuticals-takes-action-to-aid-hurricane-relief-efforts/2458007/In the wake of several devastating and destructive hurricanes in the continental US and Puerto Rico, PruGen Pharmaceuticals is helping to those in need. The PruGen Foundation, a nonprofit organization founded by PruGen Pharmaceuticals and focused on philanthropic
- Timing of Melanoma Diagnosis, Treatment Can Mean Life or Deathhttps://practicaldermatology.com/news/timing-of-melanoma-diagnosis-treatment-can-mean-life-or-death/2458004/The sooner melanoma patients are treated, the better their survival, particularly for stage I melanoma, according to a new study from the Cleveland Clinic. The research appears online today in the Journal of the
- Menlo Therapeutics Expands Management Teamhttps://practicaldermatology.com/news/menlo-therapeutics-expands-management-team/2458006/Menlo Therapeutics Inc., a late stage biopharmaceutical company, is developing a neurokinin 1 (NK‐1) receptor antagonist (serlopitant) for the treatment of pruritus associated with various underlying conditions, and for the treatment of refractory chronic cough. The company, which continues to ad
- Biofrontera Appoints Jeffrey Holm as VP of Marketinghttps://practicaldermatology.com/news/biofrontera-appoints-jeffrey-holm-as-vp-of-marketing/2458013/Biofrontera AG, which specializes in the treatment of sun-induced skin cancer, has appointmented Jeffrey Holm as Vice President of Marketing, to further strengthen its US commercialization activities.
- ASDS Elects New Officers, Board Membershttps://practicaldermatology.com/news/asds-elects-new-officers-board-members/2458016/The American Society for Dermatologic Surgery (ASDS) introduced their new Vice Presid
- ASDS Cutting Edge Research Grants Awardedhttps://practicaldermatology.com/news/asds-cutting-edge-research-grants-awarded/2458019/The American Society for Dermatologic Surgery (ASDS) awarded a total of $96,669 to ei
- Lisa M. Donofrio, MD Takes Reins of ASDS/ASDSAhttps://practicaldermatology.com/news/lisa-m-donofrio-md-takes-reins-of-asdsasdsa/2458023/Lisa M. Donofrio, MD, is the new President of the American Society for Dermatologic Surgery (ASDS) and American Society for Dermatologic Surgery Association (ASDSA). Along with her fellow officers and the ASDS / ASDSA